Zusammenfassung
Die Restenoserate nach koronarer Ballonangioplastie (PTCA) [38] und anderen perkutanen Interventionen am Koronarsystem (PCI; Rot-ablation) [49,173], Atherektomie [7,124,193],Laserangioplastie [115,172] ist trotz intensiver experimenteller und klinischer Forschungsarbeiten weiterhin hoch. Die Verwendung von Stents hat nach großen klinischen Studien die Restenoserate von etwa 40-50% auf etwa 20-30% gesenkt [20,61,188,189], eine Reihe anderer Ansätze zur Restenoseprophylaxe wie die Brachytherapie [208,210] sind derzeit in der klinischen Evaluierung (siehe S. 420-424 Status der Rezidivprophylaxe). Die hierdurch notwendigen Reinterventionen stellen bisher angesichts von jährlich mehr als einer Million Interventionen weltweit nicht nur eine große Belastung für die betroffenen Patienten dar, sondern besitzen auch erhebliche gesundheits-ökonomische Bedeutung. D a bisher keine befriedigende Lösung des Problems erreicht worden ist, wurden in den letzten Jahren auch innovative experimentelle Ansätze zur Restenoseprophylaxe evaluiert.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Afione S, Conrad C, Kearns W, Chunduru S, Adams R, Reynolds T, Guggino W, Cutting G, Carter B, Flotte T (1996) In vivo model of adenoassociated virus vector persistence and rescue. J Virol 70: 3235–3241
Akkina R, Walton R, Chen M, Li Q-X, Planelles V, Chen I (1996) High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 70:2581–2585
Akyurek L, Aoki K, Yang Z, San H, Richards M, Nabel G, Nabel E (1999) Modified thymidine kinase vector that enhances prodrug cytotoxicity. Circulation 100 (Suppl 18):Abstract #2539
Andersen H, Maeng M, Thorwest M, Falk E (1996) Remodeling rather than neointimal formation explains luminaln narrowing after deep vessel wall injury. Insights from a porcine (re)stenosis model. Circulation 93:1716–1724
Asahara T, Chen D, Tsurumi Y, Kearney M, Rossow S, Passeri J, Symes J, Isner J (1996) Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 94:3291–3302
Baek S, March K (1998) Gene therapy for restenosis. Getting nearer the heart of the matter. Circulation Res 82:295–305
Baim D, Cutlip DE, Sharma SK et al (1998) Balloon versus optimal atherectomy trial BOAT. Circulation 97:322–331
Barath P, Popov A, Michiels R (1996) Nipple balloon catheter. Seminars in Interventional Cardiology 1:43
Battler A, Scheinowitz M, Bor A et al (1993) Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium J Am Coll Cardiol 22:2001–2006
Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner J (1998) Constitutive ex-pression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97:1114–1123
Bendeck M, Zempo N, Clowes A, Galardy R, Reidy M (1994) Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circulation Res 75:539–545
Bergelson J, Krithivas A, Celi L, Droguett G, Horwitz M, Wickham T, Crowell R, Finberg R (1998) The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol 72: 415–419
Bertrand M, McFadden EP, Fruchart JC et al (1997) Effect of pravastatin on angiographic restenosis after PTCA: the PREDICT trial. J Am Coll Cardiol 30:863–869
Binley K, Iqball S, Kingsman A, Kingsman S, Naylor S (1999) An adenoviral vector regulated by hypoxia for the treatment of ischemic disease and cancer. Gene Ther 6:1721–1727
Boast K, Binley K, Jqball S et al (1999) Characterization of physiologically regulated vectors for the treatment of ischemic disease. Hum Gene Ther 10:2197–2208
Bout A, Imler J-L, Schultz H, Perricaudet M, Zurcher C, Herbrink P, Valerio D, Pavirani A (1994) In vivo adenovirus-mediated transfer of human CFTR cDNA to Rhesus monkey airway epithelium: efficacy, toxicity and safety. Gene Ther 1:385–394
Brackmann H, Aygören E, Scharrer I, Schwaab R, Hammerstein U, Oldenburg J (1993) Two years’ experience with two recombinant factor VIII concentrates. Blood Coagulation and Fibrinolysis 4:421–424
Brand K, Klocke R, Poßling A, Paul D, Strauss M (1999) Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther 6:1054–1063
Brown M, Goldstein J (1986) A receptor-mediated pathway for cholesterol homeostasis. Sci 232: 34–47
Buller C, Dzavik V, Carere R, Mancini G, Barbeau G, Lazzam C, Anderson T, Knudtson M, Marquis F-F, Suzuki T, Cohen E, Fox R, Teo K et al (1999) Primary stenting versus balloon angioplasty in occluded coronary arteries. The Total Occlusion Study of Canada (TOSCA). Circulation 100: 236–242
Califf R, Fortin D, Frid D, Harlan W, Ohman E, Bengtson J, Nelson C, Teheng J, Mark D, Stack R (1991) Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 17:2B–13B
Caplen N, Alton E, Middleton P, Dorin J, Stevenson B, Gao X, Durham S, Jeffery P, Hodson M, Coutelle C, Huang L, Porteous D, Williamson R, Geddes D (1995) Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1:39–46
Capture TCI (1997) Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 349:1429–1435
Chang M, Barr E, Seltzer J et al (1995) Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Sci 267:518–522
Chang M, Barr E, Lu M, Barton K, Leiden J (1995) Adenovirus-mediated overexpression of the cyclin/cyclin-dependent kinase inhibitor, p21, inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 96: 2260–2268
Chang M, Ohno T, Gordon D, Lu M, Nabel G, Nabel E, Leiden J (1995) Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation follwing balloon angioplasty of the rat carotid artery. Mol Med 1:172–181
Chatterjee S, Wong K (1993) Adeno-associated viral vectors for the delivery of antisense RNA. Methods - A Companion to Methods in Enzymology 5:51–60
Chen H-H, Mack L, Kelly R, Ontell M, Kochanek S, Clemens P (1997) Persistence in muscle of an adenoviral vector that lacks all viral genes. Proceedings of the National Academy of Sci USA 94:1645–1650
Claudio P, Fratta L, Farina F, Howard C, Stassi G, Numata S, Pacilio C, Davis A, Lavitrano M, Volpe M, Wilson J, Trimarco B, Giordano A, Condorelli G (1999) Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty. Circ Res 85: 1032–1039
Clemens P, Kochanek S, Sunada Y, Chan S, Chen H-H, Campbell K, Caskey C (1996) In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther 3:965–972
Clowes M, Lynch C, Miller A, Miller D, Osborne W, Clowes A (1994) Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J Clin Invest 93:644–651
Coffin R, Howard M, Cumming D, Dollery C, McEwan J, Yellon D, Marber M, MacLean A, Brown S, Latchman D (1996) Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors. Gene Ther 3:560–566
Condorelli G, Aycock J, Frati G, Napoli C (2001) Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. FASEB J 15: 2162–2170
Cotten M (1995) Adenovirus-augmented, receptor-mediated gene delivery and some solutions to the common toxicity problems. In The Molecular Repertoire of Adenoviruses. Vol 3. In: Doerfler W, Böhm P (eds) Springer, Berlin Heidelberg New York. pp 283–295
Crossart Y (1998) TTV a common virus, but pathogenic? Lancet 352(9123):164
Crystal R, McElvaney N, Rosenfeld M, Chu C, Mastrangeli A, Hay J, Brody S, Jaffe H, Eissa N, Danel C (1994) Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genetics 8:42–51
Curiel D (1999) Considerations and challenges for the achievement of targeted gene delivery (Perspective). Gene Ther 6:1497–1498
Curiel D, Agarwal S, Wagner E, Cotten M (1991) Adenovirus enhancement of transferrin-polylysine mediated gene delivery. Proceedings of the National Academy of Sci USA 88:8850–8854
Curiel D, Wagner E, Cotten M, Birnstiel M, Li M, Loechel S, Agarwal S, Hu P (1992) High efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes via an antibody bridge. Hum Gene Ther 3:147–154
Dachs G et al (1997) Targeting gene expression to hypoxic tumour cells. Nat Med 3:515–520
Defer C, Belin M-T, Caillet-Boudin M-L, Boulanger P (1990) Human adenovirus-host interactions: comparative study with members of subgroups B and C. J Virol 64:3661–3673
DeYoung M, Dichek D (1998) Gene therapy for restenosis. Are we ready? Circulation Res 82: 306–313
Di Mario C, Gil R, Camenzind E, Ozaki Y, van Birgelen C, Umans V, de Jaegere P, de Feyter P, Roelandt J, Serruys P (1995) Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. Am J Cardiol 75:772–777
Dion L, Fang J, Garver R (1996) Supernatant rescue assay versus polymerase chain reaction for detection of wild-type adenovirus-contaminated recombinant adenovirus stocks. J Virol Methods 56:99–107
Dmitriev I, Krasnykh V, Miller C, Wang M, Kashentseva E, Mikheeva G, Belousova N, Curiel D (1998) An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilizationof a coxsackievirus and adenovirus receptor-independent entry mechanism. J Virol 72:9706–9713
Edgell CJ, Curiel DT, Hu PC, Marr HS (1998) Efficient gene transfer to human endothelial cells using DNA complexed to adenovirus particles. Biotechniques 25:264–268, 270–272
Eissa N, Chu C, Danel C, Crystal R (1994) Evaluation of the respiratory epithelium of normals and individuals with cystic fibrosis for the presence of adenovirus Ela sequences relevant to the use of Ela(-) adenovirus vectors for gene therapy for the respiratory manifestations of cystic fibrosis. Hum Gene Ther 5:1105–1114
Eizema K, Fechner H, Berstarosti K, Schneider-Rasp S, vanderLaarse A, Wang H, Schultheiss H-P, Poller W, Lamers J (2000) Adenovirus-based phospholamban-antisense-mRNA expression as a novel approach to improve cardiac contractile dysfunction - Comparison of a constitutive viral versus an endothelin-l-responsive cardiac promoter. Circulation 101:2193–2199
Eltchaninoff H, Gibier A, Koning R et al (1997) Angioscopic findings of rotational atherectomy/ PTCA versus PTCA. J Am Coll Cardiol 30:888–893
Emanueli C, Salis M, Chao J, Chao L, Agata J, Lin K, Munao A, Straino S, Minasi A, Capogrossi M, Madeddu P (2000) Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice. Arterioscler Thromb Vasc Biol 20: 1459–1466
EPILOG EEiPtIL-TOwAGIIBI (1997) Platelet glycoprotein IIb/ííía receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 336:1689–1696
Eraser I (1999) Acute platelet inhibition with Abciximab does not reduce in-stent restenosis (ERASER Study). The ERASER Investigators. Circulation 100:799–806
Essen R et al (1997) Prevention of restenosis following angioplasty with octreotide: VERAS. Circulation 96:1482–1487
Fallaux F, Bout A, van der Velde I, van den Wollenberg D, Hehir K, Keegan J, Auger C, Cramer S, van Ormondt H, van der Eb A, Valerio D, Hoeben R (1998) New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 9:1909–1917
Fallaux F, Kranenburg O, Cramer S, Houweling A, van Ormondt H, Hoeben R, van der Eb A (1996) Characterization of 911: A new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 7: 215–222
Fallaux F, van der Eb A, Hoeben R (1999) Who’s afraid of replication-competent adenoviruses? (Editorial). Gene Ther 6:709–712
Fechner H, Haack A, Wang H, Wang X, Eizema K, Pauschinger M, Schoemaker R, van Veghel R, Houtsmuller A, Schultheiss H-P, Lamers J, Poller W (1999) Expression of Coxsackie-adenovirus-receptor and av-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther 6:1520–1535
Finkel T, Epstein S (1995) Gene therapy for vascular disease. FASEB Journal 9:843–851
Firth J, Ebert B, Pugh C, Ratcliffe P (1994) Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3’ enhancer. Proceedings of the National Academy of Sci USA 91:6496–6500
Fisher K, Wilson J (1994) Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer. Biochemical Journal 299:49–58
Fishman D, Leon M, Bairn D et al (1994) A randomized comparison of coronary-stent placement and ballon angioplasty in the treatment of coronary artery disease. New England J Medicine 331:496–501
Flotte T, Afione S, Conrad C, McGrath S, Solow R, Oka H, Zeitlin P, Guggino W, Carter B (1993) Stable in vivo expression of the cystic fibrosis trans-membrane conductance regulator with an adenoassociated virus vector. Proc Nat Acad Sci USA 90:10613–10617
Floyd S, Clemens P, Ontell M, Kochanek S, Day C, Yang J, Hauschka S, Balkir L, Morgan J, Moreland M, Feero G, Epperly M, Huard J (1998) Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther 5:19–30
Folkman J (1998) Angiogenic therapy of the human heart. Circulation 97:628–629
Folkman J (1998) Therapeutic angiogenesis in ischemic limbs. Circulation 97:1108–1110
Franz W, Mueller O, Fleischmann M, Babij P, Frey N, Mueller M, Besenfelder U, Moorman A, Brem G, Katus H (1999) The 2.3 kb smooth muscle myosin heavy chain promoter directs gene expression into the vascular system of transgenic mice and rabbits. Cardiovasc Res 43:1040–1048
Franz W, Rothmann T, Frey N, Katus HA (1997) Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters. Cardiovascular Res 35:560–566
Frey A, Schneider-Rasp S, Marienfeld U, Yu J-M, Paul M, Poller W, Schmidt H (1999) Biochemical and functional characterization of nitric oxide synthase III gene transfer using a replication-deficient adenoviral vector. Biochemical Pharmacology 58:1155–1166
Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E (1996) Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J Virol 70:2116–2123
Gibbons G, Dzau V (1994) The emerging concept of vascular remodeling. New England J Medicine 330:1431–1438
Gill D, Southern K, Mofford K, Seddon T, Huang L, Sorgi F, Thomson A, MacVinish L, Ratcliff R, Bilton D, Lane D, Littlewood J, Webb A, Middleton P, Colledge W, Cuthbert A, Evans M, Higgins C, Hyde S (1997) A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 4:199–209
Gilles J et al (1996) Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. J Clin Invest 97: 1382–1388
Giordano F, Ping P, McKirnan M, Nozaki S, De-Maria A, Dillmann W, Mathieu-Costello O, Hammond H (1996) Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 2:534–539
Goldman M, Su Q, Wilson J (1996) Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: implications for gene therapy of cystic fibrosis. Gene Ther 3:811–818
Grubb B, Pickles R, Ye H et al (1994) Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371: 802–806
Gruentzig A, Senning A, Siegenthaler W (1979) Nonoperative dilation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. New England J Medicine 301:61–66
Guzman R, Hirschowitz E, Brody S, Crystal R, Epstein S, Finkel T (1994) In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Nat Acad Sci USA 91:10732–10736
Hajjar R, Schmidt U, Kang J, Matsui T, Rosenzweig A (1997) Adenovirus gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca2+ATPase. Circulation Res 81: 145–153
Harada K et al (1994) Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 94:623–630
Harada M, Numaguchi Y, Osanai H, Tomida T, Toki Y, Okamura K (1999) Prostacyclin synthase gene transfer prevents neointimal formation after balloon injury in rabbits: its effect on angiogenesis. Circulation 100 (Suppl 18):I-405 (#2129)
Harada M, Numaguchi Y, Osani H, Tomida T, Toki Y, Okamura K (1999) Prostacyclin synthase gene transfer inhibits in-stent restenosis in atheromatous rabbits. Circulation 100 (Suppl 18):I-106 (#548)
Harrell R, Rajanayagam S, Doanes AM, Guzman RJ, Hirschowitz EA, Crystal RG, Epstein SE, Finkel T (1997) Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase. Circulation 96:621–627
Hasenstab D, Forough R, Clowes A (1997) Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases-2 increase after arterial injury in rats. Circulation Res 80:490–496
Hayashi K, Nakamura S, Morishita R, Moriguchi A, Aoki M, Matsumoto K, Nakamura T, Kaneda Y, Sakai N, Ogihara T (2000) In vivo transfer of human hepatocyte growth factor gene accelerates reendothelialization and inhibits neointimal formation after ballooninjury in rat model. Gene Ther 7:1664–1671
Hehir K, Armentano D, Cardoza L, Choquette T, Berthelette P, White G, Couture L, Everton M, Keegan J, Martin J, Pratt D, Smith M, Smith A, Wadsworth S (1996) Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J Virol 70:8459–8467
Hehrlein C, Stintz M, Kinscherf R et al (1996) Pure ß-particle emitting stents inhibit neointima formation in rabbits. Circulation 93:641–645
Hemmi S, Geertsen R, Mezzacasa A, Peter I, Dummer R (1998) The presence of human coxsackievirus and adenovirus is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Human Gene Ther 9:2363–2373
Hermens W, Verhaagen J (1997) Adenovirus vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: Preferential survival of transduced astroglial cells in nude rats. Human Gene Ther 8:1049–1063
Herzog R, Hagstrom J, Kung S-H, Tai S, Wilson J, Fisher K, High K (1997) Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Nat Acad Sci USA 94: 5804–5809
Hidaka C, Milano E, Leopold P, Bergelson J, Hackett N, Finberg R, Wickham T, Kovesdi I, Roelvinck P, Crystal R (1999) CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Invest 103:579–587
Hughes J (1997) Production issues in a national gene vector lab: adenovirus and AAV vector development. In: Williamsburg Bioprocessing Conference, Williamsburg, Virginia, USA
Iaccarino G, Smithwick L, Lefkowitz R, Koch W (1999) Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis. Proc Natl Acad Sci USA 96:3945–3950
Ilan Y, Droguett G, Chowdhury N, Li Y, Sengupta K, Thummala N, Davidson A, Chowdhury J, Horwitz M (1997) Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc Nat Acad Sci USA 94:2587–2592
Imler J-L, Dupuit F, Chartier C, Accart N, Dieterle A, Schultz H, Puchelle E, Pavirani A (1996) Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promotor. Gene Ther 3:49–58
Inesi G, Lewis D, Sumbilla C, Nandi A, Strock C, Huff K, Rogers T, Johns D, Kessler P, Ordahl C (1998) Cell-specific promotor in adenovirus vector for transgenic expression of SERCA1 ATPase in cardiac myocytes. Am J Physiol 273: C645–C653
Isner J, Walsh K, Symes J et al (1995) Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 901:2687–2692
Isner J, Pieczek A, Schainfeld R et al (1996) Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb. Lancet 348:370–374
Janssens S, Bloch K, Nong Z, Gerard R, Zoldhelyi P, Collen D (1996) Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest 98:317–324
Kakuta T, Currier J, Haudenschild C, Ryan T, Faxon D (1994) Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation 89:2809–2815
Kallio P, Pongratz J, Gradin K et al (1997) Activation of hypoxia-inducible factor 1 alpha: post-transcriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Nat Acad Sci USA 94:5667–5672
Kaplan J, StGeorge J, Pennington S, Keyes L, Johnson R, Wadsworth S, Smith A (1996) Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/ CFTR-2. Gene Ther 3:117–127
Kastrati A et al (1997) Restenosis in the intracoronary stenting and antithrombotic regimen trial: ISAR investigators. Circulation 96:462–467
Kay M, Holterman A, Meuse L, Gown A, Ochs H, Linsley P, Wilson C (1995) Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nature Genetics 11: 191–197
Keogh M, Chen D, Schmitt J, Dennehy U, Kakkar V, Lemoine N (1999) Design of a muscle cell-specific expression vector utilising human vascular smooth muscle alpha-actin regulatory elements. Gene Ther 6:616–628
Kim S et al (1997) Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo. J Clin Invest 100:1006–1014
King S, Williams C, Chongule P, et al (1998) Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty. Results of the Beta Energy Restenosis Trial (BERT). Circulation 97:2025–2030
Kingston P, Sinha S, David A, Castro M, Lowenstein P, Heagerty A (2001) Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition. Circulation 104:2595–2601
Klugherz B, Song C, DeFelice S, Cui X, Lu Z, Connolly J, Hinson J, Wilensky R, Levy R (2002) Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus. Hum Gene Ther 13:443–454
Knowles M, Hohnecker K, Zhou Z, Olsen J, Noah T, Hu P-C, Leigh M, Engelhardt J, Edwards L, Jones K, Grossman M, Wilson J, Johnson L, Boucher R (1995) A controlled study of adenoviral-vectormediated gene transfer in the nasal epithelium of patients with cystic fibrosis. New England J Med 333:823–831
Kobayashi K, Oka K, Forte T, Ishida B, Teng B, Ishimura-Oka K, Nakamuta M, Chan L (1996) Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J Biological Chemistry 271:6852–6860
Kochanek S, Clemens P, Mitani K, Chen H-H, Chan S, Caskey C (1996) A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Nat Acad Sci USA 93:5731–5736
Koeberl D, Alexander I, Halbert C, Russell D, Miller A (1997) Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc Nat Acad Sci USA 94:1426–1431
Koenig S (1996) A lesson from the HIV patient: The immune response is still the bane (or promise) of gene therapy. Nat Med 2:165–167
Kolls J, Lei D, Odom G, Nelson S, Summer W, Gerber M, Shellito J (1996) Use of transient CD4 lymphocyte depletion to prolong transgene expression of El-deleted adenoviral vectors. Hum Gene Ther 7:489–497
Köster R, Hamm C, Seabra-Gomes R, Herrmann G, Sievert H, Macaya C, Fleck E, Fischer K, Bonnier J, Fajadet J, Waigand J, Kuck K-H, Henry M, Morice M, Pizzulli L, Webb-Peploe M, Buchwald A, Ekström L, Grube E, Al Kasab S, Colombo A, Sanati A, Ernst S, Haude M, Leon M, Ilsley C, Beyar R, Taeymans Y, Gladbach U, Wegscheider K, Serruys P et al (1999) Laser angioplasty of restenosed coronary stents: Results of a multicenter surveillance trial. J Am Coll Cardiol 34:25–32
Krasnykh V, Dmitriev I, Mikheeva G, Miller C, Belousova N, Curiel D (1998) Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol 72:1844–1852
Kume M, Komori K, Matsumoto T, Onohara T, Takeuchi K, Yonemitsu Y, Sugimachi K (2002) Administration of a decoy against the activator protein-1 binding site suppresses neointimal thickening in rabbit balloon-injured arteries. Circulation 105:1226–1232
Kureishi Y, Witzenbichler B, LeRoux A, Branellec D, Walsh K (1999) Cell cycle-dependent regulation of migration and integrin expression in smooth muscle by the gax transcription factor. Circulation 100(Suppl 18):I-335 (#1757)
Lablanche JM, McFadden EP, Meneveau N et al (1997) Effect of nadroparin (LMWH) on restenosis after PTCA. The FACT study. Circulation 96: 3396–3402
Laird J, Carter A, Kufs W, Hoopes T, Farb A, Nott S, Fischell R, Fischell D, Virmani R, Fischell T (1996) Inhibition of neointimal proliferation with low-dose irradiation from a beta-particle-emitting stent. Circulation 93:529–536
Laitinen M, Zachary I, Breier G, Pakkanen T, YlaHerttuala S (1997) VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther 8:1737–1744
Lamfers M, Lardenoye J, de Vries M, Aalders M, Engelse M, Grimbergen J, vanHinsbergh V, Quax P (2001) In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI. Gene Ther 8:534–541
Lamphere L, Tsui L, Wick S, Nakano T, Kilinski L, Finer M, McArthur J, Gyuris J (2000) Novel chimeric p16 and p27 molecules with increased anti-proliferative activity for vascular disease gene therapy. J Mol Med 78:451–459
Lansky A, Mintz GS, Popma JJ et al (1998) Remodeling after DCA in OARS. J Am Coll Cardiol 32:329–337
Lawrie A, Brisken A, Francis S, Cumberland D, Crossman D, Newman C (2000) Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 7:2023–2027
Lazarous D et al (1995) Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91:145–153
Leon MB, Teirstein P, Moses JW et al (2001) Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 344:250–256
Lieber A, He C-Y, Kirilova I, Kay M (1996) Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J Virol 70:8944–8960
Lieber A, He C-Y, Meuse L, Himeda C, Wilson C, Kay M (1998) Inhibition of NF-?B activation in combination with Bd-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver. J Virol 72:9267–9277
Liu M-L, Winther B, Kay M (1996) Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G) - Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Virol 70:2497–2502
Lochmüller H, Jani A, Huard J, Prescott S, Simoneau M, Massie B, Karpati G, Acsadi G (1994) Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (DE1+ DE3) during multiple passages in 293 cells. Hum Gene Ther 5:1485–1491
Losordo D, Vale P, Symes J, Dunnington C, Esakof D, Maysky M, Ashare A, Lathi K, Isner J (1998) Gene therapy for myocardial angiogenesis. Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98:2800–2804
Lynch C, Hara P, Leonard J, Williams J, Dean R, Geary R (1997) Adeno-associated virus vectors for vascular gene delivery. Circulation Res 80:497–505
Macejak D, Lin H, Webb S, Chase J, Jensen K, Jarvis T, Leiden J, Couture L (1999) Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neo-intima formation in vivo. J Virol 73:7745–7751
Mann M, Gibbons G, Kernoff R, Dzau V (1994) Genetically engineered vein grafts: resistant to neointima formation and adapted to the arterial circulation. Circulation 90:I89
Mann M, Gibbons G, Kernoff R, Diet F, Tsao P, Cooke J, Kaneda Y, Dzau V (1995) Genetic engineering of vein grafts resistant to atherosclerosis. Proc Nat Acad Sci USA 92:4502–4506
Mann M, Whittemore A, Donaldson M, Belkin M, Conte M, Polak J, Orav E, Ehsan A, Dell’Acqua G, Dzau V (1999) Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomized, controlled trial. Lancet 354:1493–1498
Mann M, Whittemore A, Donaldson M, Belkin M, Conte M, Polak J, Orav J, Dzau V (1999) Gene therapy for human bypass grafts: results of a randomized, controlled trial (PREVENT). Circulation 100 (Suppl 18):I-769 (#4062)
Marienfeld U, Haack A, Thalheimer P, Schneider-Rasp S, Brackmann H-H, Poller W (1999) „Auto-replication“ of the vector genome in recombinant adenoviral vectors with different El region deletions and transgenes. Gene Ther 6:1101–1113
Mathias P, Wickham T, Moore M, Nemerow G (1994) Multiple adenovirus serotypes use alphaV integrins for infection. J Virol 68:6811–6814
McArthur J, Qian H, Citron D, Banik G, Lamphere L, Gyuris J, Tsui L, George S (2001) p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasia. Mol Ther 3:8–13
McBride W, Lange R, Hillis K (1988) Restenosis after successful coronary angioplasty: pathophysiology and prevention. New England J Med 318: 1734–1737
McLachlan G, Ho L-P, Davidson-Smith H, Samways J, Davidson H, Stevenson B, Carothers A, Alton E, Middleton P, Smith S, Kallmeyer G, Michaelis U, Seeber S, Naujoks K, Greening A, Innes J, Dorin J, Porteous D (1996) Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP. Gene Ther 3:1113–1123
Meerkin D et al (1999) Effect of b-radiation after PTCA: IVUS findings. Circulation 99:1660–1665
Mertens K, Donath M, y Leen R, d Keyzer-Nellen M, Verbeet M (1993) Biological activity of recom-binant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713Arg740. Br J Haematol 85:133–142
Mesri E, Federoff H, Brownlee M (1995) Expression of vascular endothelial growth factor from a defective herpes simplex virus type 1 amplicon vector induces angiogenesis in mice. Circulation Res 76:161–167
Michou A, Santoro L, Christ M, Julliard V, Pavirani A, Mehtali M (1997) Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of trans-gene expression. Gene Ther 4:473–482
Miller A, Bonham L, Alfano J, Kiem H-P, Reynolds T, Wolgamot G (1996) A novel murine retrovirus identified during testing for helper virus in human gene transfer trials. J Virol 70: 1804–1809
Mintz G, Popma J, Pichard A, Kent K, Satler L, Wong S et al (1996) Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study. Circulation 94:35–43
Mitani K, Graham F, Caskey C, Kochanek S (1995) Rescue, propagation, partial purification of a helper virus-dependent adenovirus vector. Proc Nat Acad Sci USA 92:3854–3858
Monahan P, Samulski R, Tazelaar J, Xiao X, Nichols T, Bellinger D, Read M, Walsh C (1998) Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther 5:40–49
Morishige K, Shimokawa H, Yamawaki T, Miyata K, Eto Y, Kandabashi T, Yogo K, Higo T, Egashira K, Ueno H, Takeshita A (2000) Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. J Am Coll Cardiol 35: 1040–1047
Morsy M, Caskey C (1999) Expanded-capacity adenoviral vectors - the helper-dependent vectors. Mol Med Today 5:18–24
Moulton K et al (1999) Plaque growth and neovascularization with angiogenesis inhibitors endostatin or TNP-470. Circulation 99:2243–2250
Muller D, Ellis S, Topol E (1992) Experimental models of coronary artery restenosis. J Am Coll Cardiol 19:418–432
Naoumov N, Petrova E, Thomas M, Williams R (1998) Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 352(9123):195–197
Nikol S, Huehns T, Krausz E, Armeanu S, Engelmann M, Winder D, Salmons B, Hoefling B (1999) Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation. Gene Ther 6:737–748
Oberhoff M, Herdeg C, Baumbach A, Karsch K (2002) Stent-based antirestenotic coatings (Sirolimus/Paclitaxel). Cathet Cardiovasc Intervent 55: 404–408
O’Blenes S, Zaidi S, Cheah A, McIntyre B, Kaneda Y, Rabinovitch M (1999) Gene transfer of the serine elastase inhibitor elafin delays neointimal formation and protects against atherosclerotic degeneration of veingrafts. Circulation 100 (Suppl 18): I-96 (#492)
Ohno T, Gordon D, San H et al (1994) Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Sci 265:781–784
Parks R, Chen L, Anton M, Sankar U, Rudnicki M, Graham F (1996) A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Nat Acad Sci USA 93:13565–13570
Paulus W, Baur I, Boyce F, Breakefield X, Reeves S (1996) Self-contained, tetracycline-regulated retro-viral vector system for gene delivery to mammalian cells. J Virol 70:62–67
Pavlides G, Barath P, Maginas A, Vasilikos V, Cokkinos D, O’Neil W (1997) Intramural drug delivery by direct injection within the arterial wall: first clinical experience with a novel intracoronary delivery-infiltrator system. Cath Cardiovas Diagn 41:287–292
Peel A, Zolotukhin S, Schrimsher G, Muzyczka N, Reier P (1997) Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promotors. Gene Ther 4:16–24
Pittman D, Alderman E, Tomkinson K, Wang J, Giles A, Kaufman R (1993) Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Blood 81:2925–2935
Poller W, Schneider-Rasp S, Liebert U, Merklein F, Thalheimer P, Haack A, Schwaab R, Schmitt C, Brackmann H-H (1996) Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host. Gene Ther 3:521–530
Porteous D, Dorin J, McLachlan G, Davidson-Smith H, Davidson H, Stevenson B, Carothers A, Wallace W, Moralee S, Hoenes C, Kallmeyer G, Michaelis U, Naujoks K, Ho L-P, Samways J, Imrie M, Greening A, Innes J (1997) Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 4:210–218
Post M, Borst C, Kuntz R (1994) The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 89:2816–2821
Prentice H, Bishopric NH, Hicks NM et al (1997) Regulated expression of a foreign gene targeted to the ischemic myocardium Cardiovasc Res 35: 567–574
Rade J, Schulick A, Virmani R, Dichek D (1996) Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat Med 2:293–298
Raizner A, Oesterle S, Waksman R et al (2000) Inhibition of restenosis with bety-emitting radiotherapy: report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 102:951–958
Reifart N, Vandormael M, Krajcar M et al (1997) Excimer laser, rotational atherectomy, balloon angioplasty comparison study: ERBAC. Circulation 96:91–98
Reisman M, Buchbinder M, Harms V et al (1998) QCA 24 hours after rotational atherectomy. Am J Cardiol 81:1427–1432
Ribault S, Neuville P, Mechine-Neuville A, Auge F, Parlakian A, Gabbiani G, Paulin D, Calenda V (2001) Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy. Circ Res 88: 468–475
Richter M, Iwata A, Nyhuis J, Nitta Y, Miller A, Halbert C, Allen M (2000) Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol Genom 2:117–127
Rinsch C et al (1997) A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum Gene Ther 8:1881–1889
Rosenfeld M, Yoshimura K, Trapnell B, Yoneyama K, Rosenthal E, Dalemans W, Fukayama M, Bargon J, Stier L, Stratford-Perricaudet L, Perricaudet M, Guggino W, Pavirani A, Lecocq J-P, Crystal R (1992) In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143–155
Rosenfeld M, Rosenfeld S, Danel C, Banks T, Crystal R (1994) Increasing expression of the normal human CFTR cDNA in cystic fibrosis epithelial cells results in a progressive increase in the level of CFTR protein expression, but a limit on the level of cAMP-stimulated chloride secretion. Hum Gene Ther 5:1121–1129
Rosengart T, Lee L, Patel S, Sanborn T, Parikh M, Bergman G, Hachamovitch R, Devereux R, Post M, Hackett N, Foster T, Grasso T, Lesser M, Isom O, Crystal R (1999) Angiogenesis gene therapy. Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100:468–474
Rubenstein R, McVeigh U, Flotte T, Guggino W, Zeitlin P (1997) CFTR gene transduction in neonatal rabbits using an adeno-associated virus (AAV) vector. Gene Ther 4:384–392
Scarborough R, Kleiman N, Phillips D (1999) Platelet glcyoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use? Circulation 100:437–444
Schaper W, Ito W (1996) Molecular mechanisms of collateral vessel growth. Circulation Res 79: 911–919
Schowalter D, Tubb J, Liu M, Wilson C, Kay M (1997) Heterologous expression of adenovirus E3-gpl9k in an Ela-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo. Gene Ther 4:351–360
Schumacher B, Pecher P, von Specht B, Stegmann T (1998) Induction of neoangiogenesis in ische-mic myocardium by human growth factors. First clinical results of a new treatment of coronary heart disease. Circulation 97:645–650
Schwartz R, Abildgaard C, Aledort L, Arkin S, Bloom A, Brackmann H, et al. (1990) Hum recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A - Recombinant Factor VIII Study Group. New Engl J Med 323:1800–1805
Scott N, Cipolla G, Ross C, Dunn B, Martin F, Simonet L et al (1996) Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93:2178–1287
Semenza G, Nejfelt M, Chi S, Antonarakis S (1991) Hypoxia-inducible nuclear factors bind to an enhancer element located 3’ to the human erythropoietin gene. Proc Nat Acad Sci USA 88: 5680–5684
Serruys P, de Jaegere P, Kiemeneij F et al (1994) A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. New England J Med 331: 489–495
Serruys P, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel M-A et al (1998) Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 352(9129):673–681
Shi Y, Pieniek M, Fard A, O’Brien J, Mannion J, Zalewski A (1996) Adventitial remodeling after coronary artery injury. Circulation 93:340–348
Simari R, San H, Rekhter M, Ohno T, Gordon D, Nabel G, Nabel E (1996) Regulation of cell proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest 98:225–235
Simon R, Engelhardt J, Yang Y, Zapeda M, Weber-Pendleton S, Grossman M, Wilson J (1993) Adenovirus-mediated gene transfer of the CFTR gene to lungs of nonhuman primates: toxicity study. Hum Gene Ther 4:771–780
Simonton C, Leon MB, Baim DS et al (1998) Optimal atherectomy restenosis study: OARS. Circulation 97:332–339
Skelly C, Curi M, Meyerson S, Woo D, Hari D, Vosicky J, Advani S, Mauceri H, Glagov S, Roizman B, Weichselbaum R, Schwartz L (2001) Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo. Gene Ther 8:1840–1846
Smith K, Shepherd A, Boyd J, Lees G (1996) Gene delivery systems for use in gene therapy: an overview of quality assurance and safety issues. Gene Ther 3:190–200
Smith R, Branellec D, Gorski D, Guo K, Perlman H, Dedieu J, Pastore C, Mahfoudi A, Denefle P, Isner J, Walsh K (1997) p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Gen Develop 11:1674–1689
Starr P, Lim F, Grant F, Trask L, Lang P, Yu L, Geller A (1996) Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression. Gene Ther 3:615–623
Steg P, Feldman L, Scoazec J-Y, Tahlil O, Barry J, Boulechfar S, Ragot T, Isner J, Perricaudet M (1994) Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation 90: 1648–1656
Stevenson S, Rollence M, White B, Weaver L, McClelland A (1995) Hum adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J Virol 69:2850–2857
StGeorge J, Pennington S, Kaplan J, Peterson P, Kleine L, Smith A, Wadsworth S (1996) Biological response of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2) Gene Ther 3:103–116
Strayer M, Guttentag S, Ballard P (1998) Targeting type II and Clara cells for adenovirus-mediated gene transfer using surfactant protein B promotor. Am J Resp Cell Mol Biol 18:1–11
Su J, Fukuda N, Hu W, Kanmatsuse K (2000) Ribozyme to human TGF-betal mRNA inhibits the proliferation of human vascular smooth muscle cells. Biochem Biophys Res Commun 278:401–407
Sun T-Q, Fenstermacher D, Vos J-M (1994) Humanartificial episomal chromosomes for cloning large DNA in human cells. Nat Genet 8:33–41
Sun T-Q, Livanos E, Vos J-M (1996) Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes. Gene Ther 3:1081–1088
Takeshita S, Zheng LP, Brogi E et al (1994) Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93:662–670
Takeshita S, Rossow ST, Kearney M et al (1995) Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 147: 1649–1660
Taniyama Y, Tachibana K, Hiraoka K, Namba T, Yamasaki K, Hashiya N, Aoki M, Ogihara T, Yasufumi K, Morishita R (2002) Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 105:1233–1239
Teirstein P (1997) ß-radiation to reduce restenosis. Too little, too soon? Circulation 95:1095–1097
Teirstein P, Massullo V, Jani S et al (1999) Two-year follow-up of the SCRIPPS trial. Circulation 99:243–247
Teirstein P, Massullo V, Jani S, Popma J, Mintz G, Russo R, Schatz R, Guarneri E, Steuterman S, Morris N, Leon M, Tripuraneni P (1997) Catheter-based radiotherapy to inhibit restenosis after coronary stenting. New Engl J Med 336:1697–1703
Teramoto S, Bartlett J, McCarty D, Xiao X, Samulski R, Boucher R (1998) Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: Comparison with adenovirus vectors. J Virol 72:8904–8912
Tomko R, Xu R, Philipson L (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Nat Acad Sci USA 94:3352–3356
Tripathy S, Black H, Goldwasser E, Leiden J (1996) Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2:545–550
Tsui L, Camrud A, Mondesire J, Carlson P, Zayek N, Camrud L, Donahue B, Bauer S, Lin A, Frey D, Rivkin M, Subramanian A, Falotico R, Gyuris J, Schwartz R, McArthur J (2001) p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion. Circ Res 89:323–328
Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner J (1997) Reciprocal Relationship between VEGF and NO in the regulation of endothelial integrity. Nat Med 3:879–886
Ueno H, Yamamoto H, Ito S, Li J, Takeshita A (1997) Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo. Arteriosclerosis Thromb Vasc Biol 17:898–904
Vale P, Losordo D, Tkebuchava T, Chen D, Milliken C, Isner J (1999) Catheter-based myocardial gene transfer using nonfluoroscopic electromechanical left ventricular mapping. J Am Coll Cardiol 34:246–254
Van Belle E, Tio F, Chen D, Maillard L, Chen D, Kearney M, Isner J (1997) Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol 29:1371–1379
Varenne O, Pislaru S, Gillijns H, Gerard R, Van de Werf F, Collen D, Janssens S (1997) Adenoviral gene transfer of human constitutive endothelial nitric oxide synthase to injured coronary arteries. J Am Coll Cardio 29:380A (abstract)
Venkatesh V, Planer B, Schwartz M, Vanderbilt J, White R, Ballard P (1995) Characterization of the promoter of human pulmonary surfactant protein B gene. Am J Physiol 268:L674–L682
Verin VPY, de Bruyne B et al (2001) Endoluminal Beta-Radiation Therapy for the Prevention of Coronary Restenosis after Balloon Angioplasty. N Engl J Med 344:243–249
von der Leyen H, Gibbons G, Morishita R, Lewis N, Zhang L, Nakajima M, Kaneda Y, Cooke J, Dzau V (1995) Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Nat Acad Sci USA 92:1137–1141
Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler K, Curiel D, Birnstiel M (1992) Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Nat Acad Sci USA 89:6099–6103
Waksman R, White R, Chan R et al (2000) Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 101:2165–2171
Wang G, Jiang B, Rue E, Semenza G (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helixPAS heterodimer regulated by cellular 02 tension. Proc Nat Acad Sci USA 92:5510–5514
Wickham T, Mathias P, Cheresh D, Nemerow G (1993) Integrins avß3 and avß5 promote adenovirus internalization but not virus attachment. Cell 309–319
Wickham T, Tzeng E, Shears L, Roelvink P, Li Y, Lee G, Brough D, Lizonova A, Kovesdi I (1997) Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol 71:8221–8229
Wilson C, Kay M (1995) Immunomodulation to enhance gene therapy. Nat Med 1:887–889
Witzenbichler B, Kureishi Y, Luo Z, LeRoux A, Branellec D, Walsh K (1999) Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor. J Clin Invest 104: 1469–1480
Wohlgemuth J, Kang S, Bulboaca G, Nawotka K, Calos M (1996) Long-term gene expression from autonomously replicating vectors in mammalian cells. Gene Ther 3:503–512
Wright M, de Alwis M, Latchman D, Thrasher A, Marber M (1998) Recombinant adeno-associated virus-mediated gene transfer in the in vivo rabbit myocardium. European Heart Journal 19 (Abstract supplement):478
Xiao W, Berta S, Lu M, Moscioni D, Tazelaar J, Wilson J (1998) Adeno-associated virus as a vector for liver-directed gene therapy. J Virol 72 (12):10222–10226
Xu F, Prescott M, Liu P, Chen Z, Liau G, Gordon E, Hall F (2001) Long term inhibition of neointima formation in balloon-injured rat arteries by intraluminal instillation of a matrix-targeted retroviral vector bearing a cytocidal mutant cyclin G1 construct. Int J Mol Med 8:19–30
Yanagisawa-Miwa A, et al (1992) Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Sci 257:1401–1403
Yang Y, Wilson J (1995) Clearance of adenovirusinfected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J Immunol 155:2564–2570
Yang Y, Hildegund C, Wilson J (1994) MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses Immun 1:433–442
Yang Y, Nunes F, Berencsi K, Furth E, Gönczöl E, Wilson J (1994) Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Nat Acad Sci USA 91:4407–4411
Yang Y, Trinchieri G, Wilson J (1995) Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med 1:890–893
Yang Y, Li Q, Ertl H, Wilson J (1995) Cellular and humoral immune response to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69:2004–2015
Yang Y, Jooss K, Su Q, Ertl H, Wilson J (1996) Immune response to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 3: 137–144
Yei S, Mittereder N, Tang K, O’Sullivan C, Trapnell B (1994) Adenovirus-mediated gene transfer for systic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther 1:192–200
Zabner J, Couture L, Gregory R, Graham S, Smith A, Welsh M (1993) Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:207–216
Zabner J, Ramsey BW, Meeker DP et al (1996) Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest 97:1504
Zinn K, Douglas J, Smyth C, Liu H-G, Wu Q, Krasnykh V, Mountz J, Curiel D, Mountz J (1998) Imaging and tissue biodistribution of 99mTclabeled adenovirus knob (serotype 5). Gene Ther 5:798–808
Zoldhelyi P, McNatt J, Xu X-M, Loose-Mitchell D, Leidell R, Clubb F, Buja M, Willerson J, Wu K (1996) Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. Circulation 93:10–17
Zufferey R, Dull T, Mandel R, Bukovsky A, Quiroz D, Naldini L, Trono D (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72:9873–9880
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Poller, W., Schultheiss, HP. (2002). Biologische Rezidivprophylaxe. In: Vallbracht, C., Roth, FJ., Strauss, A.L. (eds) Interventionelle Gefäßtherapie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57540-2_38
Download citation
DOI: https://doi.org/10.1007/978-3-642-57540-2_38
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63296-9
Online ISBN: 978-3-642-57540-2
eBook Packages: Springer Book Archive